"Based on the multiethnic LEADER population, among individuals currently attending NHS Health Checks, it is more cost-effective to screen for diabetes using a HbA1c test than using a FPG test. However, in some localities, the prevalence of diabetes and high risk of diabetes may be higher for FPG relative to HbA1c than in the LEADER cohort."
The cost-effectiveness of testing strategies for type 2 diabetes: a modelling study
Gillett M, Brennan A, Watson P, Khunti K, Davies M, Mostafa S, et al.
Health Technology Assessment 2015;19(33)
Read more here.
No comments:
Post a Comment